Cerulean Pharma (CERU) Priced

Developing targeted therapies for kidney, ovarian and other cancers.

Health Care - Biotechnology

IPO Performance
Latest Trade $1.38 -0.03 (-2.1%)
First Day Return -2.1%
Return from IPO -79.9%
 
Cerulean Pharma IPO News more
  • .
IPO Data
IPO File Date 03/10/2014
Offer Price $7.00
Price Range $11.00 - $13.00
Offer Shares (mm) 8.5
Deal Size ($mm) 60
 
IPO Data
IPO Date 04/09/2014
Offer Price $7.00
Price Range $11.00 - $13.00
Offer Shares (mm) 8.5
Deal Size ($mm) $60
 
Underwriters
more
Business Overview
Developing targeted therapies for kidney, ovarian and other cancers.
Developing targeted therapies for kidney, ovarian and other cancers.
more
Company Data
Headquarters Cambridge, MA
Founded 2005
Employees 21
Website www.ceruleanrx.com
 

Performance vs. IPO Index (IPOUSA)